WHO ICTRP trial
Efficacy and safety study of an Epoetin alfa in Thai patients under CAPD.
TCTR20140128002 · Thai Clinical Trials Registry (TCTR) · Recruiting
Key facts
| Trial ID | TCTR20140128002 |
|---|---|
| Public title | Efficacy and safety study of an Epoetin alfa in Thai patients under CAPD. |
| Scientific title | An open-label prospective study to evaluate the efficacy and safety of a recombinant human Erythropoietin (Hema-Plus) for the management of anemia in patients on peritoneal dialysis |
| Primary sponsor | Apexcela, Co., Ltd. |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Thaialnd |
| Conditions | Renal anemia renal anemia anemia in chronic kidney disease;renal anemia anemia in chronic kidney disease |
| Interventions | Epoetin alfa 4000 IU SC initially once a week, dosage adjustment can be performed during the treatment period upon investigator discretion;Experimental Biological/Vaccine;Epoetin alfa |
| Registration date | Jan 28, 2014 |
| Target size | 30 |
| Secondary IDs | APXF001-01 |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: